Off‐label uses of ustekinumab
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15910
Abstract: Ustekinumab (brand name Stelara®) is a human interleukin‐12 and ‐23 antagonist and has been indicated for the treatments of moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This review aims to… read more here.
Keywords: uses ustekinumab; psoriasis; label uses;